Clinical Trial Update: Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating octreotide for locally advanced or metastatic liver cancer has been completed, per UNC Lineberger's update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• OCTREOTIDE (OCTREOTIDE ACETATE)

Snippet

Sponsor: UNC Lineberger Comprehensive Cancer Center | Conditions: Liver Cancer | Phase 2 | Status: COMPLETED